AzTrials
AzTrials

Facial Nerve ParesisNCT05568108

Using the Masseteric Nerve for Facial Nerve Reanimation

An observational study of Facial Nerve Paresis, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The return of eyelid function and facial expression in Patients with facial nerve affection is very important for quality of life. Eyelid dysfunction leads to drying and ulceration of cornea which may lead to permanent vision loss. Read more about this study

Who is it for?
Any age
Conditions the study is for
Facial Nerve Paresis
What is being tested?
masseteric nerve to central branch facial nerve and Masseteric nerve to free functioning muscle transfer
Type of treatment
Surgery or procedure
How many people
24 participants
Where
1 siteEgypt
Study dates
4 Nov 2020to 1 Apr 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Facial nerve affection patients

Who may be able to join

  • Facial nerve affection
  • Patients are generally fit with no other disease interfere with microsurgery.
  • Electromyography showing fibrillations for group A and no fibrillation for group B.

Who cannot join

  • Patient with other medical or mental disease-causing generalized paralysis.
  • Syndromic cases.
  • Patients are generally unfit or with any disease interfere with microsurgery.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Plastic Surgery Department Assiut University

    Asyut, 71511

    Ahmed M refaat, MCCh

    Recruiting

Other trials in Egypt

About this study

Official title: Using the Masseteric Nerve for Facial Nerve Reanimation: A Clinical Study.

The return of eyelid function and facial expression in Patients with facial nerve affection is very important for quality of life. Eyelid dysfunction leads to drying and ulceration of cornea which may lead to permanent vision loss.

Facial paralysis is distinguished into two main groups according to the presence or absence of facial fibrillations at needle Electromyography. Recent paralysis, mainly lasting less than two years generally show these signs and are eligible for reactivation of facial nerve by anastomosing it to a donor one (early facial reanimation).

The masseteric nerve (motor branch of trigeminal nerve ) is a reliable donor nerve on early facial reanimation So on this study we examine the advantages and disadvantages of using masseteric nerve to develop a protocol for use of facial reanimation and restoration of function on facial paresis.

Read the detailed description

Type of the study: observtional Study (clinical trial)

Intervention Model Description:

Patients will be two groups according to the surgical procedure performed as follows:

  • Group A: masseteric nerve to central branch facial nerve. (Early fibrillation on EMG)
  • Group B: Masseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG)

Allocation and Randomization:

Twenty-four patients will be assigned to Group A early or Group B late (2 groups). group A will be for early and be will be for late cases

Study Setting: Plastic and Reconstructive Surgery Department, Assuit University Hospital and San Paolo university hospital of Milano university.

Study subjects:

Inclusion criteria:

1.Facial nerve affection 2.Patients are generally fit with no other disease interfere with microsurgery. 3.Electromyography showing fibrillations for group A and no fibrillation for group B.

  1. Exclusion criteria:

1.Patient with other medical or mental disease-causing generalized paralysis. 2.Syndromic cases. 3.Patients are generally unfit or with any disease interfere with microsurgery.

  1. Sample Size Calculation: 24 Sample size was calculated using G power program version 3.1.9.4 (6) in order to detect a significant difference in mean of EFACE score (one of main assessed outcomes in the study ) between two groups under the study , assumed effect size 0.6 based on clinical assumption ( novel study ), α error 0.3 , power 0.80, and allocation ratio 1: 1.

Twenty-two patient plus 10% for dropouts to make total twenty-four (12 patient for every group).

Study tools

All patients in this study are subjected to:

Pre-operative Assessment:

  1. Patient history.
  2. All patients will do preoperative clinical and neurophysiological assessments of mimetic muscle function and donor nerve status (the ipsilateral deep temporal nerve. The neurophysiological tests will include needle Electromyography (EMG) for recruitment of residual motor unit action potential to determine which procedure
  3. The trigeminal motor component will be tested by palpating the temporalis muscle and masseteric muscle during chewing and via needle EMG to verify availability as a donor motor nerve.
  4. Photographic documentation preoperative using standardized EFACE view.
  5. Ophthalmological assessment of the affected eye for detection of redness, ulcer, etc.

Surgical procedure:

Group A the investigators will avoid the use of muscle relaxants to induce anaesthesia and employ an electro-stimulator to identify the masseteric nerve and the facial nerve branches supplying the affected side.

Exploration on the affected side a facelift-type incision will be performed, and an anterior subcutaneous flap is then will be lifted for several centimetres. In the inferior zygomatic region, the plane of elevation is deepened into the sub-SMAS plane and a composite flap elevated for several centimetres. Following elevation in this plane, the distal facial nerve branches will be identified. The distal portion of the zygomatic nerve is usually located midway between the oral commissure and the helical root. and was confirmed by nerve stimulator.

Then masseteric nerve identified in masseteric muscle and then end to end anastomosis with the central branch of facial nerve Then suction drain will be put and will be removed after 24 hours. Group B The same technique of face lift and harvest the free functioning muscle flap and micro anastomosis of the flap for the superficial temporal system or the facial artery system and the same technique for masseteric nerve identification and end to end anastomosis and to side for prepare cross nerve form the stage one Post-operative All patient will receive physiotherapy and post-operative follow up to detect any wound complication.

Evaluation (After 6 months from the operation)

  1. Photo documentation for EFACE
  2. Donor site morbidity.
  3. Onset of first movement
  4. Patient satisfaction

Complications:

  1. General surgical complication.
  2. General complication due to general anaesthesia.
  3. Specific complication:
  4. Delayed healing of nerve anastomosis.
  5. Affection of mastication.
  6. No postoperative improvement.

Research outcome measures:

  1. Primary (main): Comparing the outcomes on EFACE score

Secondary (subsidiary):

  1. Easy technique for rapid masseteric nerve identification.
  2. Effect of addition of contracted growth factor around the anastomosis
  3. Procedure-related morbidity and mortality.
  4. Effect of selective neurectomy for overactive affected branches with the total reanimation
  5. The experience of adding another neural impots with masseteric nerve
  6. Operative time and hospital stay.
Being tested
masseteric nerve to central branch facial nerve, Masseteric nerve to free functioning muscle transfer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • masseteric nerve to central branch facial nerveProcedure or surgery

    masseteric nerve to central branch facial nerve. (Early fibrillation on EMG)

  • Masseteric nerve to free functioning muscle transferProcedure or surgery

    Masseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG)

Study groups in NCT05568108
Study groupRoleWhat they receive
nerve transfermasseteric nerve to central branch facial nerve. (Early fibrillation on EMG)
Receives: Procedure: masseteric nerve to central branch facial nerve
nerve and free functioning muscle transferMasseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG)
Receives: Procedure: Masseteric nerve to free functioning muscle transfer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparing the outcomes on EFACE score

    difference on the score

    Measured: up to one year

Secondary outcomes (1)
  1. Effect of addition of contracted growth factor around the anastomosis

    time for nerve activation

    Measured: up to one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2022
  2. Study start4 Nov 2020
  3. Primary completion1 Jan 2023 (estimated)
  4. Study completion1 Apr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05568108
Sponsor's protocol ID
Masseteric for facial nerve
Status last verified
Oct 2022
First submitted
3 Oct 2022
Last updated
6 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Facial Nerve Paresis, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed M refaat, MCCh (00201008022747, ahmed.abdelkarim@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparing the outcomes on EFACE score (time frame: up to one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in